About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab

NCT02200354·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Kobe City General Hospital

Age

20–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

20 Years and older
PS0-2
Advanced non-squamous non-small cell lung cancer; AND
Patients who have received more than 4 cycles of pemetrexed therapy before the study

You may not be if

Interstitial pneumonia; AND
Abnormal blood test

The record

StatusTerminated

PhasePhase 2

Taking part20

StartedJul 2014

UpdatedAug 14, 2019

Conditions

Advanced Non-small Cell Lung Cancer

Where1

Kobe City Medical Center General Hospital
Kobe, Hyōgo, Japan

Clareo Health | The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab